Bangkok Dusit Medical Services Public (BDMS.BK) Earnings Analysis
Bangkok Dusit Medical Services Public (BDMS.BK) next reports earnings on 2026-08-13, consensus EPS 0.2158 THB. Last quarter (2025-11-10) it beat with EPS 0.2693 THB vs 0.2588 THB est (+4.1%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 19.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BDMS.BK next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | 0.2158 THB |
| Revenue estimate | 27.03B |
BDMS.BK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-10 | 0.2693 THB | 0.2588 THB | +4.1% | Beat |
| 2025-08-11 | 0.2193 THB | 0.2222 THB | -1.3% | Miss |
| 2025-05-12 | 0.2636 THB | 0.2656 THB | -0.8% | Miss |
| 2025-02-26 | 0.2684 THB | 0.2525 THB | +6.3% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
BDMS.BK valuation and analyst view
| Trailing P/E | 19.59 |
|---|---|
| Trailing EPS | 0.9791 THB |
| Price / book | 2.77 |
| Dividend yield | 5.21% |
| Market cap | 309.89B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bangkok Dusit Medical Services Public (BDMS.BK)'s next earnings date?
Bangkok Dusit Medical Services Public is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 0.2158 THB and revenue estimate of 27.03B.
Did BDMS.BK beat earnings last quarter?
In its 2025-11-10 report, BDMS.BK posted EPS of 0.2693 THB versus a 0.2588 THB estimate — a beat of 4.1%.
What is BDMS.BK's earnings track record?
Over the last 4 reported quarters with consensus data, BDMS.BK beat estimates 2 times (50%).
What is BDMS.BK's current P/E ratio and EPS?
BDMS.BK trades at a trailing P/E of 19.59 on trailing EPS of 0.9790986686258912 THB.
What do analysts rate BDMS.BK?
BDMS.BK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.